2Von-Marschall Z,Cramer T, Hocker M, et al. Dual Mechanism of VEGF Upregulation by Hypoxia in Human Hcc[M]. Gut, 2001,48(1):87-96.
3Kim Y-B, Park YN, Park C. Increased Proliferation Activities of Vascular Endothelial Cells and Tumor Cells in Residual Hepatocellular Carcinoma Following Transcatheter Arterial Embolization[J]. Histopathology, 2001,38(2):160-166.
5Wild R, Ramakrishnan S, Sedgewiek J, et al. Quantitative Assessment of Angiogenesis and Tumor Vessel Arehheeture by Computer-Assisted Digital Image Analysis:Effects of VEGF Toxin Conjugate on Tumor MVD[J]. Microvasc Res,2000,59(3):368.
6Benjamin LE, Golijanin D, Itin A, et al. Selective Ablation of Immature Blood Vessels in Established Human Tumors Follows VEGF Withdrawal[J]. J clin Invest, 1999,103(2):159-165.
7Gunga HC,Kirsh K,Rocker L,et al. VEGF in Exercising Humans under Different Environmental Conditions[J]. Eur J Appl physiol,1999,79(6):484-490.
8Norio H, Hisashi T, Mitsuo T, et al. Hepatocyte Growth Factor Promotes Hepatocarcinogenesis Through c-Met Autocrine Activation and Enhanced Angiogenesis in Transgenic Mice Treated with Diethylnitrosamine[J]. Oncogene, 2002,21(12):1791.
9Gale NW,Yancopoulos GD. Growth Factors Acting via Endothelial Cell-Specific Receptor Tyrosine Kinases: VEGFs, Angiopoietins,and Ephrins in Vascular Development [J]. Genes Dev, 1999,13(7):1055-1066.
10Ferrara N,Alitalo K. Clinical Applications of Angiogenic Growth Factors and their Inhibitors[J]. Nat Med,1999,5(6):1359-1364.
二级参考文献39
1[1]EI-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver[J]. Hepatology, 1998,27:1554 - 1562.
2[2]Sun HC, Tang ZY, Li XM, et al. Microvessel density of hepatocellular carcinoma: its relationship with prognosis[J]. J Cancer Res Clin Oncol, 1999,125: 419 - 426.
3[3]Kimura H, Nakajima T, Kagawa K, et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry [J]. Liver,1998,18:14- 19.
4[4]Ker CG, Chen HY,Juan CC, et al. Role of angiogenesis in hepatitis and hepatocellular carcinoma [J]. Hepatogastroenterology, 1999, 46: 646-650.
5[5]Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement [J]. Cancer Res, 1997,57:4777 - 4786.
6[6]Takahashi Y, Bucana CD, Cleary KR, et al. P53, vessel count and vascular endothelial growth factor expression in human colon cancer[J]. Int J Cancer, 1998,79:34 - 38.
7[7]Tanigawa N, Lu C, Mitsui T, et al. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance[J].Hepatology, 1997,26:1216 - 1223.
8[8]Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor(VPF, VEGF) in tumor biology[J]. Cancer Metastasis Rev, 1993,12:303 - 324.
9[9]Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis[J]. Radiology, 1996,200:639 -649.
10[10]Hawighorst H, Knapstein PG, Knopp MV. Uterine cervical carcinoma:comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival[J].Cancer Res, 1998,58:3598 - 3602.
9Mitchell DG,Rubin R,Siegelman ES,et al.Hepatocellular carcinoma within siderotic regenerative nodules:appearance as anodule within a nodule on MR images[J].Radiology,1991,178(1):101-103.
10Efremidis SC,Hytiroglbu P.The multistep process of hepatocarcinogenesisin cirrhosiswith imaging correlation (Review)[J].Eur Radiol,2002,12(4):753-764.
